Reborna Biosciences, Inc. logo

Reborna Biosciences, Inc. jobs and careers

Japan

About Reborna Biosciences, Inc.

Reborna Biosciences is a Japan based startup company developing RNA-targeting small molecule drugs for rare genetic diseases. Our proprietary screening method discovers orally available small molecules by reproducing the natural three-dimensional structure of RNA that exists in human body. Therefore, it can be expected to identify drug candidates having a higher extrapolation to clinical practice than the conventional screening method using artificially fragmented RNA (a form that does not exist in the body). We are convinced that this unique technology will contribute to the development of therapeutic drugs with higher efficacy and fewer side effects.

Founded in 2018 by Koji Fuji.

Founded
2018
Employees
1 to 10
Total funding
$256M
Headquarters
Japan

Leadership

The top of Reborna Biosciences, Inc.'s org chart, with how many people report into each leader.

KF

Koji Fuji

Representative Director, CEO/COO